60
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Unveiling Key Pathological Indicators for Disease Progression in Vogt Koyanagi Harada Disease and Sympathetic Ophthalmia Through Advanced Choroidal Volume Analysis

, MD, , MD, PhDORCID Icon, , MSc, , PhD, , PhD, , MD, PhD, , MD, PhD, , MD, PhD, , PhD & , MD, PhD show all
Received 24 Aug 2023, Accepted 27 Mar 2024, Published online: 06 May 2024

References

  • Sugita S, Takase H, Taguchi C, et al. Ocular infiltrating CD4+ T cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest Ophthalmol Vis Sci. 2006;47(6):2547–2554. doi:10.1167/iovs.05-1547.
  • Imai Y, Sugita M, Nakamura S, Toriyama S, Ohno S. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada’s disease. Curr Eye Res. 2001;22(4):312–318. doi:10.1076/ceyr.22.4.312.5510.
  • Chen L, Yang P, Zhou H. et al. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome. Invest Ophthalmol Vis Sci. 2008;49(8):3475–3482. doi:10.1167/iovs.08-1793.
  • Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of vogt–koyanagi–harada disease. Retina. 2011;31(3):510–517. doi:10.1097/IAE.0b013e3181eef053.
  • Iwahashi C, Okuno K, Hashida N, Nakai K, Ohguro N, Nishida K. Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals. Jpn J Ophthalmol. 2015;59(3):157–163. doi:10.1007/s10384-015-0377-1.
  • Okunuki Y, Tsubota K, Kezuka T, Goto H. Differences in the clinical features of two types of Vogt-Koyanagi-Harada disease: serous retinal detachment and optic disc swelling. Jpn J Ophthalmol. 2015;59(2):103–108. doi:10.1007/s10384-014-0367-8.
  • Maruyama K, Noguchi A, Shimizu A, Shiga Y, Kunikata H, Nakazawa T. Predictors of recurrence in Vogt-Koyanagi-Harada Disease. Ophthalmol Retina. 2018;2(4):343–350. doi:10.1016/j.oret.2017.07.016.
  • Maruyama K, Mei S, Sakaguchi H, et al. Diagnosis of choroidal disease with deep learning-based image enhancement and volumetric quantification of optical coherence tomography. Transl Vis Sci Technol. 2022;11(1):22. doi:10.1167/tvst.11.1.22.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature11The authors constitute the international committee on Vogt-Koyanagi-Harada disease nomenclature, representing the participants of the First International Workshop on Vogt-Koyanagi-Harada Disease. A full list of participants appears at the end of the article. Am J Ophthalmol. 2001;131(5):647–652. doi:10.1016/S0002-9394(01)00925-4.
  • Maruyama K. Current standardized therapeutic approach for uveitis in Japan. Immunol Med. 2019;42(3):124–134. doi:10.1080/25785826.2019.1678961.
  • Herbort CP Jr., Abu El Asrar AM, Takeuchi M, et al. Catching the therapeutic window of opportunity in early initial-onset Vogt–Koyanagi–Harada uveitis can cure the disease. Int Ophthalmol. 2019;39(6):1419–1425. doi:10.1007/s10792-018-0949-4.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516.
  • Mao Z, Miki A, Mei S, et al. Deep learning based noise reduction method for automatic 3D segmentation of the anterior of lamina cribrosa in optical coherence tomography volumetric scans. Biomed Opt Express. 2019;10(11):5832–5851. doi:10.1364/BOE.10.005832.
  • Hojjatoleslami A, Avanaki MRN. OCT skin image enhancement through attenuation compensation. Appl Opt. 2012;51(21):4927–4935. doi:10.1364/AO.51.004927.
  • Mari JM, Strouthidis NG, Park SC, Girard MJA. Enhancement of lamina cribrosa visibility in optical coherence tomography images using adaptive compensation. Invest Opthalmol Visual Sci. 2013;54(3):2238. doi:10.1167/iovs.12-11327.
  • Paris S, Hasinoff SW, Kautz J. Local Laplacian filters. Commun ACM. 2015;58(3):81–91. doi:10.1145/2723694.
  • Pizer SM, Amburn EP, Austin JD, et al. Adaptive histogram equalization and its variations. Computer Vision, Graphics, And Image Processing. 1987;39(3):355–368. doi:10.1016/S0734-189X(87)80186-X.
  • Laboratory TABI. Improved choroid layer segmentation using the Topcon Advanced Boundary Segmentation (TABSTM) algorithm with DRI OCT-1 Images. White paper.
  • Sonoda S, Sakamoto T, Yamashita T. et al, Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. Am J Ophthalmol. 2015;159(6):1123–1131.e1. doi:10.1016/j.ajo.2015.03.005.
  • Agrawal R, Gupta P, Tan K-A, Cheung CMG, Wong T-Y, Cheng C-Y. Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study. Sci Rep. 2016;6(1):6. doi:10.1038/srep21090.
  • Zhou H, Dai Y, Shi Y, et al. Age-related changes in choroidal thickness and the volume of vessels and stroma using swept-source OCT and fully automated algorithms. Ophthalmol Retina. 2020;4(2):204–215. doi:10.1016/j.oret.2019.09.012.
  • Childs H, Brugger E, Whitlock B, et al. VisIt: An End-User tool for visualizing and analyzing very large data. In: High Performance Visualization–Enabling Extreme-Scale Scientific Insight. 2012;357–372.
  • Takemoto Y, Namba K, Mizuuchi K, et al. Choroidal circulation impairment during the anterior recurrence of Vogt–Koyanagi–Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy. Acta Ophthalmol. 2016;94(7):e629–e636. doi:10.1111/aos.13024.
  • Hirooka K, Saito W, Namba K. et al, Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt–Koyanagi–Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015;253(4):609–617. doi:10.1007/s00417-014-2927-5.
  • Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology. 2001;108(1):54–64. doi:10.1016/S0161-6420(00)00428-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.